Efficacy of assisted reproductive technology after ovarian tissue transplantation in a cohort of 11 patients with or without associated infertility factors.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 02 08 2020
accepted: 10 12 2020
pubmed: 4 1 2021
medline: 1 7 2021
entrez: 3 1 2021
Statut: ppublish

Résumé

IVF treatment in women with grafted frozen-thawed ovarian tissue is associated with poor reproductive outcomes. The aim of this study was to evaluate the efficacy of ovarian tissue transplantation (OTT) followed by assisted reproductive technology (ART) in women with or without associated infertility factors. This is a prospective cohort study with retrospective data collection including eleven women, four of whom having an infertility factor (IF), who had undergone OTT in one university center between 2005 and 2017, followed by ART in six in vitro fertilization (IVF) centers. In total, 25 of the 85 cycles initiated (29%) were canceled, resulting in 60 oocyte retrievals. Ninety-five oocytes were retrieved: 36 were abnormal or immature, 29/39 fertilized (74%) after ICSI and 13/20 (65%) after IVF. Thirty-five embryos were transferred in seven patients (5/7 patients without IF and 2/4 patients with IF). After ART, one patient with IF experienced two pregnancies, one resulting in a live birth. For all patients, pregnancy rates and live birth rates were 7.4% and 3.7% per embryo transfer, respectively. Nine pregnancies and four live births occurred after spontaneous conception in five patients without IF, none in the infertility group. This study confirms that IVF treatment in women with grafted frozen-thawed ovarian tissue is associated with poor outcomes. However, the chances of natural conception are high in women without IF. Patients with IF, without the possibility of spontaneous pregnancy, should be informed of poor reproductive outcomes after OTT followed by ART. NCT02184806.

Identifiants

pubmed: 33389379
doi: 10.1007/s10815-020-02033-9
pii: 10.1007/s10815-020-02033-9
pmc: PMC7884571
doi:

Banques de données

ClinicalTrials.gov
['NCT02184806']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

503-511

Références

Fertil Steril. 2020 Aug;114(2):379-387
pubmed: 32624219
Haematologica. 2019 Aug;104(8):e360-e363
pubmed: 30765476
J Korean Med Sci. 2018 Apr 30;33(21):e156
pubmed: 29780295
Clin Med Insights Reprod Health. 2019 Aug 06;13:1179558119867357
pubmed: 31431803
Hum Reprod. 2006 Aug;21(8):2006-9
pubmed: 16684840
Fertil Steril. 2019 Nov;112(5):908-921
pubmed: 31594631
J Ovarian Res. 2013 May 07;6(1):33
pubmed: 23647552
Fertil Steril. 2011 Feb;95(2):695-701
pubmed: 20828687
Hum Reprod. 2002 Jun;17(6):1447-52
pubmed: 12042259
N Engl J Med. 2005 Jul 21;353(3):318-21
pubmed: 15983020
Lancet. 2004 Oct 16-22;364(9443):1405-10
pubmed: 15488215
Fertil Steril. 2010 Jan;93(1):268.e11-3
pubmed: 19880105
Fertil Steril. 2008 Jul;90(1):23-32
pubmed: 17761177
Lancet. 2004 Mar 13;363(9412):837-40
pubmed: 15031026
Hum Reprod. 2013 Nov;28(11):2996-9
pubmed: 24014608
Reprod Biomed Online. 2012 Aug;25(2):128-32
pubmed: 22687323
Hum Reprod. 2019 Jun 4;34(6):1083-1094
pubmed: 31116405
Hum Reprod. 2009 Nov;24(11):2778-87
pubmed: 19671623
Fertil Steril. 2019 Feb;111(2):408-410
pubmed: 30691635
Fertil Steril. 2016 Aug;106(2):467-74
pubmed: 27181924
Expert Rev Endocrinol Metab. 2018 May;13(3):125-136
pubmed: 30058903

Auteurs

M Vatel (M)

Department of Reproductive Medicine, Clinique de la Muette, 75116, Paris, France.

A Torre (A)

Division of Child Health, Department of Obstetrics and Gynaecology, University of Nottingham, Nottingham, UK.

B Paillusson (B)

Department of Reproductive Medicine, Poissy Saint-Germain-en-Laye Hospital, 78300, Poissy, France.

F Scheffler (F)

Department of Reproductive Medicine, Amiens Hospital, 80054, Amiens, France.

M Bergere (M)

Department of Reproductive Biology, Poissy Saint-Germain-en-Laye Hospital, 78300, Poissy, France.

M Benkhalifa (M)

Medicine and Reproductive Biology, University Hospital and School of Medicine, Picardy Jules Verne University, 80054, Amiens, France.
Peritox-INERIS, UMR-I 01, Joint Research Centre, Picardy Jules Verne University, 80054, Amiens, France.

M-T Le Martelot (MT)

Department of Reproductive Medicine, Brest Hospital, 29200, Brest, France.

F Leperlier (F)

Department of Reproductive Medicine and Biology, Nantes Hospital, 44000, Nantes, France.

S Mirallié (S)

Department of Reproductive Medicine and Biology, Nantes Hospital, 44000, Nantes, France.

L Selleret (L)

Department of Gynecology and Obstetrics, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, 75020, Paris, France.

M Prades-Borio (M)

Department of Reproductive Biology, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, 75020, Paris, France.

A Neuraz (A)

Department of Gynecology and Obstetrics, Les Bluets Hospital, 75012, Paris, France.

V Barraud-Lange (V)

Department of Reproductive Biology, Assistance Publique-Hôpitaux de Paris (AP-HP), Cochin Hospital, 75014, Paris, France.

N Boissel (N)

Department of Hematology, Adolescents and Young Adults Unit, Fertility Preservation, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, 1 Avenue Claude Vellefaux, 75010, Paris, France.
Paris University, EA3518, 75006, Paris, France.

A Fortin (A)

Department of Obstetrics and Gynecology, Assistance Publique des Hôpitaux de Paris (AP-HP), Pitié-Salpétrière Hospital, 75013, Paris, France.

C Poirot (C)

Department of Hematology, Adolescents and Young Adults Unit, Fertility Preservation, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, 1 Avenue Claude Vellefaux, 75010, Paris, France. catherine.poirot@aphp.fr.
Médecine Sorbonne University, 75005, Paris, France. catherine.poirot@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH